FRESENIUS MED CARE AG&CO KGA's ticker is FMS and the CUSIP is 358029106. A total of 179 filers reported holding FRESENIUS MED CARE AG&CO KGA in Q2 2020. The put-call ratio across all filers is 34.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $205,000 | -16.0% | 5,875 | +0.2% | 0.00% | – |
| Q2 2021 | $244,000 | +11.4% | 5,864 | -1.3% | 0.00% | – |
| Q1 2021 | $219,000 | -10.2% | 5,944 | +1.4% | 0.00% | – |
| Q4 2020 | $244,000 | -2.0% | 5,864 | 0.0% | 0.00% | – |
| Q3 2020 | $249,000 | -2.0% | 5,864 | 0.0% | 0.00% | – |
| Q2 2020 | $254,000 | +17.6% | 5,864 | 0.0% | 0.00% | – |
| Q4 2019 | $216,000 | -6.1% | 5,864 | 0.0% | 0.00% | – |
| Q2 2019 | $230,000 | -3.4% | 5,864 | 0.0% | 0.00% | – |
| Q1 2019 | $238,000 | -83.0% | 5,864 | -86.4% | 0.00% | -100.0% |
| Q4 2018 | $1,402,000 | -47.2% | 43,263 | -16.2% | 0.00% | -33.3% |
| Q3 2018 | $2,656,000 | -4.0% | 51,641 | -6.0% | 0.00% | 0.0% |
| Q2 2018 | $2,766,000 | -3.1% | 54,928 | -1.7% | 0.00% | 0.0% |
| Q1 2018 | $2,854,000 | -2.5% | 55,867 | +0.3% | 0.00% | 0.0% |
| Q4 2017 | $2,928,000 | +8.5% | 55,720 | +1.0% | 0.00% | 0.0% |
| Q3 2017 | $2,698,000 | +5.2% | 55,188 | +4.0% | 0.00% | 0.0% |
| Q2 2017 | $2,565,000 | +22.5% | 53,081 | +6.8% | 0.00% | 0.0% |
| Q1 2017 | $2,094,000 | +3.0% | 49,711 | +3.2% | 0.00% | 0.0% |
| Q4 2016 | $2,033,000 | +3.6% | 48,174 | +7.5% | 0.00% | 0.0% |
| Q3 2016 | $1,962,000 | +28.6% | 44,821 | +27.9% | 0.00% | +50.0% |
| Q2 2016 | $1,526,000 | +0.5% | 35,034 | +1.7% | 0.00% | 0.0% |
| Q1 2016 | $1,518,000 | +3.3% | 34,444 | -1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,470,000 | +16.0% | 35,128 | +8.2% | 0.00% | 0.0% |
| Q3 2015 | $1,267,000 | -3.6% | 32,479 | +2.8% | 0.00% | +100.0% |
| Q2 2015 | $1,314,000 | +8.6% | 31,606 | +8.2% | 0.00% | 0.0% |
| Q1 2015 | $1,210,000 | +0.1% | 29,201 | -10.4% | 0.00% | 0.0% |
| Q4 2014 | $1,209,000 | +4.3% | 32,573 | -2.5% | 0.00% | 0.0% |
| Q3 2014 | $1,159,000 | -0.2% | 33,410 | -3.6% | 0.00% | 0.0% |
| Q2 2014 | $1,161,000 | -30.4% | 34,655 | -27.6% | 0.00% | -50.0% |
| Q1 2014 | $1,668,000 | -9.2% | 47,857 | -7.3% | 0.00% | 0.0% |
| Q4 2013 | $1,837,000 | -94.4% | 51,623 | -89.8% | 0.00% | -90.0% |
| Q3 2013 | $32,975,000 | +1412.6% | 503,919 | +715.4% | 0.02% | +566.7% |
| Q2 2013 | $2,180,000 | – | 61,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMBIAR INVESTORS LLC | 2,383,684 | $104,334,000 | 1.52% |
| Lombard Odier & Cie (Canada), Limited Partnership | 11,000 | $483,000 | 1.37% |
| HARDING LOEVNER LP | 3,332,640 | $145,870,000 | 1.05% |
| Norman Fields, Gottscho Capital Management, LLC | 31,172 | $1,364,000 | 0.90% |
| Sivik Global Healthcare LLC | 40,000 | $1,751,000 | 0.88% |
| SEARLE & CO. | 23,288 | $998,000 | 0.87% |
| Hardman Johnston Global Advisors LLC | 355,976 | $15,581,000 | 0.71% |
| MARATHON ASSET MANAGEMENT LLP | 668,200 | $29,361,000 | 0.63% |
| Lombard Odier Transatlantic Ltd | 6,950 | $305,000 | 0.29% |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | 132,501 | $5,800,000 | 0.25% |